CN114829372A - 镇痛和麻醉的肽及其他试剂 - Google Patents

镇痛和麻醉的肽及其他试剂 Download PDF

Info

Publication number
CN114829372A
CN114829372A CN202080085732.9A CN202080085732A CN114829372A CN 114829372 A CN114829372 A CN 114829372A CN 202080085732 A CN202080085732 A CN 202080085732A CN 114829372 A CN114829372 A CN 114829372A
Authority
CN
China
Prior art keywords
peptide
pain
peptides
injection
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080085732.9A
Other languages
English (en)
Chinese (zh)
Inventor
A·巴塔查杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation of the State University of New York
Original Assignee
Research Foundation of the State University of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation of the State University of New York filed Critical Research Foundation of the State University of New York
Publication of CN114829372A publication Critical patent/CN114829372A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202080085732.9A 2019-10-10 2020-10-12 镇痛和麻醉的肽及其他试剂 Pending CN114829372A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962913512P 2019-10-10 2019-10-10
US62/913,512 2019-10-10
PCT/US2020/055289 WO2021072392A1 (en) 2019-10-10 2020-10-12 Analgesic and anesthetic peptides and other agents

Publications (1)

Publication Number Publication Date
CN114829372A true CN114829372A (zh) 2022-07-29

Family

ID=75437541

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080085732.9A Pending CN114829372A (zh) 2019-10-10 2020-10-12 镇痛和麻醉的肽及其他试剂

Country Status (10)

Country Link
US (1) US20240294571A1 (https=)
EP (1) EP4051690A4 (https=)
JP (1) JP2022551467A (https=)
KR (1) KR20220079651A (https=)
CN (1) CN114829372A (https=)
AU (1) AU2020364246A1 (https=)
BR (1) BR112022006862A2 (https=)
CA (1) CA3157686A1 (https=)
IL (1) IL292102A (https=)
WO (1) WO2021072392A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025029752A2 (en) * 2023-07-28 2025-02-06 Gate Science, Inc. Methods and systems for pain management and testing thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1607799A (en) * 1997-11-26 1999-06-15 Zymogenetics Inc. Mammalian cytokine-like polypeptide-10
CN1466466A (zh) * 2000-09-08 2004-01-07 ��һ��������ҩ��ʽ���� 心衰治疗剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU733719B2 (en) * 1996-10-23 2001-05-24 Trustees Of The University Of Pennsylvania, The Improved vaccines
PL2211873T3 (pl) * 2007-10-22 2013-01-31 Amorphical Ltd Stabilny amorficzny węglan wapnia wchodzący w skład fosforylowanych aminokwasów
WO2012019192A2 (en) * 2010-08-06 2012-02-09 Mount Sinai School Of Medicine Cell-permeable molecules as growth factor receptor antagonists
CN111712252A (zh) * 2017-12-13 2020-09-25 纽约州立大学研究基金会 用于治疗疼痛和提高疼痛敏感性的肽和其它药剂
CN112218650A (zh) * 2018-01-15 2021-01-12 单侧Ip私人有限公司 肽及其用途

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1607799A (en) * 1997-11-26 1999-06-15 Zymogenetics Inc. Mammalian cytokine-like polypeptide-10
CN1466466A (zh) * 2000-09-08 2004-01-07 ��һ��������ҩ��ʽ���� 心衰治疗剂

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BERNARD T KELLY ET AL: "A structural explanation for the binding of endocytic dileucine motifs by the AP2 complex", NATURE, vol. 456, no. 7224, 18 December 2008 (2008-12-18), pages 976 - 979, XP055816521, DOI: 10.1038/nature07422 *

Also Published As

Publication number Publication date
JP2022551467A (ja) 2022-12-09
CA3157686A1 (en) 2021-04-15
AU2020364246A1 (en) 2022-05-12
US20240294571A1 (en) 2024-09-05
KR20220079651A (ko) 2022-06-13
IL292102A (en) 2022-06-01
WO2021072392A1 (en) 2021-04-15
BR112022006862A2 (pt) 2022-07-05
EP4051690A1 (en) 2022-09-07
EP4051690A4 (en) 2024-01-17

Similar Documents

Publication Publication Date Title
US20080187543A1 (en) Use of Myostatin (Gdf-8) Antagonists for Improving Wound Healing and Preventing Fibrotic Disease
AU2019219743B2 (en) TATk-CDKL5 fusion proteins, compositions, formulations, and use thereof
Powell et al. Inhibiting endocytosis in CGRP+ nociceptors attenuates inflammatory pain-like behavior
US12077610B2 (en) Peptides and other agents for treating pain and increasing pain sensitivity
Yaden et al. Inhibition of activin A ameliorates skeletal muscle injury and rescues contractile properties by inducing efficient remodeling in female mice
KR20070100241A (ko) 척수 외상 통증을 위한 말초로 전달된 글루탐산데카르복실라제 유전자 치료법
US20210268072A1 (en) TATk-CDKL5 Fusion Proteins, Compositions, Formulations, and Use Thereof
CN105848720A (zh) 用于诱导葡萄糖摄取的方法
KR102128003B1 (ko) 분리된 미토콘드리아를 포함하는 건병증 예방 또는 치료용 약학 조성물
WO2011148200A1 (en) Treatment of pain
CN114829372A (zh) 镇痛和麻醉的肽及其他试剂
KR20130027016A (ko) 포유류와 인간 세포에서 ｈｉｖ 복제를 억제하는 방법
US20200000888A1 (en) Compositions and methods of treating root avulsion injury
Lai et al. CtBP1 is essential for epigenetic silencing of μ-opioid receptor genes in the dorsal root ganglion in spinal nerve ligation-induced neuropathic pain
WO2025017057A1 (en) Peptides for use in the treatment of axonal damage in diabetes
KR102213878B1 (ko) Pat4를 포함하는 만성통증 질환 예방, 개선 또는 치료용 조성물
US7507716B2 (en) Method for treating pain with prolactin antagonists
Powell II Nociceptor Endocytosis Regulates Inflammatory Pain
CN121695274A (zh) 抑郁症的治疗方法和药物组合物
Thakor Development of a novel sensory neuron gene delivery platform with concomitant investigation of messenger ribonucleic acid translocation for the NaV1. 8 sodium channel during neuropathic pain
NZ749459A (en) TATĸ-CDKL5 FUSION PROTEINS, COMPOSITIONS, FORMULATIONS, AND USE THEREOF

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20220729

WD01 Invention patent application deemed withdrawn after publication